arrow
H

Hasan Hashem

king hussein cancer center
H指数:20
被引数:1,314

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide

仅临床风险因素无法预测造血细胞移植及移植后环磷酰胺治疗中中重度慢性移植物抗宿主病的发展

2026-10-290
PRE
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysis

十二年同种异基因造血干细胞移植(HSCT)在东地中海(EM)地区的应用与结果:一项多中心EMBMT注册分析

2026-04-010
PRE
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT

异基因造血细胞移植后出血性膀胱炎的发病率和结局:EBMT传染病工作组的一项调查

2026-03-260
PRE
Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 Disease
2026-02-040
OAAI
Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant Recipients

年龄对儿科造血细胞移植受者移植物抗宿主病和总生存期的影响

2025-12-160
OAAI
Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Earlier Initiation of Immunosuppression

异基因外周血造血干细胞移植术后使用环磷酰胺并早期启动免疫抑制治疗的结局

2025-02-010
PRE
Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation

种族和民族对脐血移植后结局的影响

2024-10-010
PRE
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis

≥ 1年异基因造血干细胞移植幸存者长期结果的种族和社会经济差异: CIBMTR分析

2023-11-016
PRE
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
2023-06-011
OAAI
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

调整接受异基因造血干细胞移植的患有血液系统恶性肿瘤的儿童,青少年和年轻人的hct-ci定义

2023-02-016
OAAI
Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases

扩展的hct-ci定义更好地捕获了非恶性疾病的同种异体HCT年轻患者的合并症

2023-02-013
OAAI
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy

慢性移植物抗宿主病与异基因造血干细胞移植治疗儿童血液系统恶性肿瘤的晚期效应

2022-10-019
OAAI
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation
2022-06-0118
OAAI